Veru Inc. VERU
NASDAQ VERU
$2.14 +0.02 (+0.94%)
At close: Nov 11, 2026 · 4:00 PM EST

Veru (VERU) Income from Discontinued Operations (2023 - 2026)

Updated

Veru's Income from Discontinued Operations was $351,418 in fiscal Q2 2026 (quarter ended Mar 31, 2026), compared with -$49,226 a year earlier.

Analysis

Veru (VERU) Income from Discontinued Operations (2023 - 2026) Analysis & Trends

From fiscal Q1 2024 onward, Veru has reported Income from Discontinued Operations for 7 quarters.

Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Discontinued) (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn -
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn -
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn -
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn -
5 Novartis Ag 311.58 Bn 285.16 Bn - -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn -
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn -
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn -
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn -
10 Veru 48.87 Mn -61.41 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2026 351,418.00
Jun 30, 2025 -9,719.00
Mar 31, 2025 -49,226.00
Dec 31, 2024 -7.14 Mn
Jun 30, 2024 -628,818.00
Mar 31, 2024 -1.32 Mn
Dec 31, 2023 -608,598.00
API Access

Veru Income from Discontinued Operations API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=income-from-discontinued-operations&ticker=VERU&period=max&api_key=YOUR_API_KEY